Search by Drug Name or NDC
NDC 68163-0747-04 DRx Choice Children daytime 20; 200 mg/20mL; mg/20mL Details
DRx Choice Children daytime 20; 200 mg/20mL; mg/20mL
DRx Choice Children daytime is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by RARITAN PHARMACEUTICALS. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.
MedlinePlus Drug Summary
Dextromethorphan is used to temporarily relieve cough caused by the common cold, the flu, or other conditions. Dextromethorphan will relieve a cough but will not treat the cause of the cough or speed recovery. Dextromethorphan is in a class of medications called antitussives. It works by decreasing activity in the part of the brain that causes coughing.
Related Packages: 68163-0747-04Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Dextromethorphan
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 68163-0747-04Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Guaifenesin
Product Information
| NDC | 68163-0747 |
|---|---|
| Product ID | 68163-747_25fff2a6-ecb1-4117-bd11-e5ec3e3d09a9 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | DRx Choice Children daytime |
| Proprietary Name Suffix | Cough and Chest Congestion |
| Non-Proprietary Name | Dextromethorphan HBr and Guaifenesin |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | LIQUID |
| Route | ORAL |
| Active Ingredient Strength | 20; 200 |
| Active Ingredient Units | mg/20mL; mg/20mL |
| Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN |
| Labeler Name | RARITAN PHARMACEUTICALS |
| Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Ant |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68163-0747-04 (68163074704)
| NDC Package Code | 68163-747-04 |
|---|---|
| Billing NDC | 68163074704 |
| Package | 1 BOTTLE in 1 CARTON (68163-747-04) / 118 mL in 1 BOTTLE |
| Marketing Start Date | 2023-04-24 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |